Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023
Viactiv® Generated Net Revenues of Approximately $3.3 Million for the Three Months Ended September 30, 2023, an increase of 27% over the Three Months Ended September 30, 2022
Related news for (GHSI)
- 24/7 Market News- Guardion Health Sciences BoD Declares $5 Per Share Cash Dividend
- guardion health sciences declares cash dividend of $5.00 per share of common stock
- Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.
- Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023